Experimental and computational results for different ruthenium nitrosyl porphyrin complexes [(Por)Ru(NO)(X)] ( n+ ) (where Por (2-) = tetraphenylporphyrin dianion (TPP (2 (-) )) or octaethylporphyrin dianion (OEP (2-)) and X = H 2O ( n = 1, 2, 3) or pyridine, 4-cyanopyridine, or 4- N,N-dimethylaminopyridine ( n = 1, 0)) are reported with respect to their electron-transfer behavior. The structure of [(TPP)Ru(NO)(H 2O)]BF 4 is established as an {MNO} species with an almost-linear RuNO arrangement at 178.1(3) degrees . The compound [(Por)Ru(NO)(H 2O)]BF 4 undergoes two reversible one-electron oxidation processes. Spectroelectrochemical measurements (IR, UV-vis-NIR, and EPR) indicate that the first oxidation occurs on the porphyrin ring, as evident from the appearance of diagnostic porphyrin radical-anion vibrational bands (1530 cm (-1) for OEP (*-) and 1290 cm (-1) for TPP (*-)), from the small shift of approximately 20 cm (-1) for nu NO and from the EPR signal at g iso approximately 2.00. The second oxidation, which was found to be electrochemically reversible for the OEP compound, shows a 55 cm (-1) shift in nu NO, suggesting a partially metal-centered process. The compounds [(Por)Ru(NO)(X)]BF 4, where X = pyridines, undergo a reversible one-electron reduction. The site of the reduction was determined by spectroelectrochemical studies to be NO-centered with a ca. -300 cm (-1) shift in nu NO. The EPR response of the NO (*) complexes was essentially unaffected by the variation in the substituted pyridines X. DFT calculations support the interpretation of the experimental results because the HOMO of [(TPP)Ru(NO)(X)] (+), where X = H 2O or pyridines, was calculated to be centered at the porphyrin pi system, whereas the LUMO of [(TPP)Ru(NO)(X)] (+) has about 50% pi*(NO) character. This confirms that the (first) oxidation of [(Por)Ru(NO)(H 2O)] (+) occurs on the porphyrin ring wheras the reduction of [(Por)Ru(NO)(X)] (+) is largely NO-centered with the metal remaining in the low-spin ruthenium(II) state throughout. The 4% pyridine contribution to the LUMO of [(TPP)Ru(NO)(py)] (+) is correlated with the stability of the reduced form as opposed to that of the aqua complex.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ic702371t | DOI Listing |
ACS Omega
January 2025
Department of Chemical Engineering, Norwegian University of Science and Technology (NTNU), Sem Sælands vei 4, NO-7491 Trondheim, Norway.
The Ostwald process is one of the commercial pathways for the production of nitric acid (HNO), a key component in the production of nitrate fertilizers. The Ostwald process is a mature, extensively studied, and highly optimized process, and there is still room for further intensification. The process can be further intensified by catalyzing the homogeneous oxidation of nitric oxide to nitrogen dioxide.
View Article and Find Full Text PDFChem Biol Interact
January 2025
Department of Biological Chemistry, Regional University of Cariri, 63105-000, Crato, CE, Brazil.
Radiat Prot Dosimetry
November 2024
Department of Radioecology, Institute for Environmental Sciences, 1-7, Ienomae, Obuchi, Rokkasho, Kamikita, Aomori, 039-3212, Japan.
Inorg Chem
November 2024
São Carlos Institute of Chemistry, University of São Paulo, São Carlos 13560-970, SP,Brazil.
Ruthenium(II) tetraamine nitrosyl complexes with N-heterocyclic ligands are known for their potential as nitric oxide (NO) donors, capable of releasing NO through either direct photodissociation or one-electron reduction of the Ru(II)NO center. This study delivers a novel insight into the one-electron reduction mechanism for the model complex -[Ru(NO)(NH)(py)] (RuNOpy, py = pyridine) in phosphate buffer solution (pH 7.4).
View Article and Find Full Text PDFAdv Mater
December 2024
Songjiang Research Institute, Shanghai Key Laboratory of Emotions and Affective Disorders (LEAD), Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 201600, China.
Conventional bone tissue engineering materials struggle to reinstate physiological bone remodeling in a diabetic context, primarily due to the compromised repolarization of proinflammatory macrophages to anti-inflammatory macrophages. Here, leveraging single-cell RNA sequencing (scRNA-seq) technology, the pivotal role of nitric oxide (NO) and reactive oxygen species (ROS) is unveiled in impeding macrophage repolarization during physiological bone remodeling amidst diabetes. Guided by scRNA-seq analysis, we engineer a multienzymatic bone tissue engineering hydrogel scaffold (MEBTHS) composed is engineered of methylpropenylated gelatin hydrogel integrated with ruthenium nanozymes, possessing both Ru and Ru components.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!